144 related articles for article (PubMed ID: 27993021)
1. Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles Inhibit α-Synuclein Fibrillation and Reduce Its Cytotoxicity-Associated Effects.
Taebnia N; Morshedi D; Yaghmaei S; Aliakbari F; Rahimi F; Arpanaei A
Langmuir; 2016 Dec; 32(50):13394-13402. PubMed ID: 27993021
[TBL] [Abstract][Full Text] [Related]
2. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement.
Hartono SB; Hadisoewignyo L; Yang Y; Meka AK; Antaresti ; Yu C
Nanotechnology; 2016 Dec; 27(50):505605. PubMed ID: 27875331
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
5. [The protective effects of curcumin loaded mesoporous silica nanoparticles on rat cardiomyocytes].
Fu HN; Wu L; Duan LW; Lü SZ
Yao Xue Xue Bao; 2017 Mar; 52(3):468-73. PubMed ID: 29979866
[TBL] [Abstract][Full Text] [Related]
6. [Preparation and anti-cancer activity in vitro of curcumin loaded mesoporous silica nanoparticle].
He LL; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(21):4189-93. PubMed ID: 27071254
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy.
Wang J; Wang Y; Liu Q; Yang L; Zhu R; Yu C; Wang S
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26511-26523. PubMed ID: 27619078
[TBL] [Abstract][Full Text] [Related]
8. Co-Delivery of Cisplatin and Curcumin Using Mesoporous Silica Nanoparticles to Improve their Anticancer Effects.
Dizaj SM; Bolouri Ebrahimi SS; Jafari S; Basiri A; Yazdani J; Sharifi S; Abdolahinia ED
Pharm Nanotechnol; 2023; 11(4):364-372. PubMed ID: 36974418
[TBL] [Abstract][Full Text] [Related]
9. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect.
Lin J; Cai Q; Tang Y; Xu Y; Wang Q; Li T; Xu H; Wang S; Fan K; Liu Z; Jin Y; Lin D
Int J Pharm; 2018 Jan; 536(1):272-282. PubMed ID: 29079221
[TBL] [Abstract][Full Text] [Related]
10. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
[TBL] [Abstract][Full Text] [Related]
12. Enhanced functional properties of biopolymer film incorporated with curcurmin-loaded mesoporous silica nanoparticles for food packaging.
Wu C; Zhu Y; Wu T; Wang L; Yuan Y; Chen J; Hu Y; Pang J
Food Chem; 2019 Aug; 288():139-145. PubMed ID: 30902273
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
Qu Q; Ma X; Zhao Y
Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
[TBL] [Abstract][Full Text] [Related]
14. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery.
Lungare S; Hallam K; Badhan RK
Int J Pharm; 2016 Nov; 513(1-2):280-293. PubMed ID: 27633279
[TBL] [Abstract][Full Text] [Related]
15. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
16. Polyethylenimine-mediated synthetic insertion of gold nanoparticles into mesoporous silica nanoparticles for drug loading and biocatalysis.
Pandey PC; Pandey G; Narayan RJ
Biointerphases; 2017 Mar; 12(1):011005. PubMed ID: 28347142
[TBL] [Abstract][Full Text] [Related]
17. Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment.
Kotcherlakota R; Barui AK; Prashar S; Fajardo M; Briones D; Rodríguez-Diéguez A; Patra CR; Gómez-Ruiz S
Biomater Sci; 2016 Mar; 4(3):448-59. PubMed ID: 26674254
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of a Soybean Bowman-Birk Inhibitor (BBI) Nanodelivery Carrier To Improve Bioavailability of Curcumin.
Liu C; Cheng F; Yang X
J Agric Food Chem; 2017 Mar; 65(11):2426-2434. PubMed ID: 28249113
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
